Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$410.3M
141M shares
52-week range
$2.41 – $4.43
28% from low
Sector
SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
Exchange
NYSE
CS
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
www.chs.netNo one on the platform currently holds CYH.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-09-30 | 467,793 | $1.5M |
No one on the platform has traded CYH yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$CYH https://anachart.com/wp-content/uploads/2026/07/1785160986_soc-img.jpg
Fundamental analysis of $CYH (COMMUNITY HEALTH SYSTEMS INC) based on financial data and reported results. #CYH
View on StockTwits ↗$CYH If you're gonna buy ... we're scraping the bottom of the barrel here. Check back in 5 years.
View on StockTwits ↗Pre-Market Fly By for Thursday, July 23rd: Breaking Stock Market News $GOOGL $TSLA $AAL $CYH $NOW
View on StockTwits ↗$CYH will be watching to maybe trade this like a smallcap today
View on StockTwits ↗$CYH Typical Wall St. See these news events from a week ago. One was a reality warning shot that carried actual weight (the top one), the other was Wall Streets attempt to hold the stock price up so they could exit at peak prices and unload to the gullible masses before CYH reported their earnings. Being that they are in the same industry, it was going to have to take Wall Street Bankster effort to keep the CYH price from falling on the same news.
View on StockTwits ↗$CYH | Community Health Systems Q2 Earnings Community Health Systems reported a weak quarter. • Adj. EPS: -$0.19 vs -$0.06 est. • Revenue: $2.825B, down 9.83% YoY from $3.133B FY2026 Guidance lowered: • GAAP EPS: -$1.25 to -$1.10 • Revenue: $11.4B to $11.6B Both earnings and revenue came in below expectations, with guidance reduced. See through the market fog like the Alpha Owl. Like & follow for sharp, daily signals.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $11.5B | -8.3% | $-1.13 | $-1.61–$-0.21 | — | 3 |
| 2027 | $11.5B | +0.7% | $-0.47 | $-0.55–$-0.38 | — | 4 |
| 2028 | $11.8B | +2.7% | $-0.42 | $-0.51–$-0.33 | — | 2 |
| 2029 | $14.6B | +22.8% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-22 | $-0.10 | $-0.19 | -83.4% |
| 2026-04-21 | $-0.11 | $-0.48 | -323.1% |
| 2026-02-18 | $-0.20 | $-0.01 | +95.1% |
| 2025-10-23 | $-0.28 | $1.27 | +557.4% |
| 2025-07-23 | $0.05 | $-0.05 | -200.0% |
| 2025-04-23 | $-0.10 | $-0.03 | +70.0% |
| 2025-02-18 | $0.09 | $-0.42 | -566.7% |
| 2024-10-23 | $-0.16 |
| $-0.30 |
| -87.5% |
| $707M |
| — |
| FDMT4D Molecular Therapeutics, Inc. | $11.65 | -1.85% | $609M | — |
| INNVInnovage Holding Corp. | $10.65 | +2.11% | $1.4B | — |
Source: Financial Modeling Prep · peers by sector/industry